Georges Caputo

Georges Caputo

Auto-generated profile, based on publicly available information

Georges Caputo

Pediatric Ophthalmology Department (Y.A., R.L., M.E.H., P.D., G.C., F.M., T.C.), Rothschild Foundation Hospital, Paris, France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Retina
Verified
Journal Article
Closed access
GCGeorges Caputo
Georges Caputo
RHRaoul de Haller
Raoul de Haller
FMFlorence Metge
Florence Metge
PDPascal Dureau
Pascal Dureau
Ocular lesions known to occur after shaken baby syndrome (SBS) are epiretinal, intraretinal, and subretinal hemorrhages, which are present in up to 100% of patients. Retinoschisis and retinal folds have also been described. We describe three patients with SBS who presented with tractional retinal detachments secondary to neovascular proliferation and discuss the role of ischemia at the retinal level. Three patients (two 4-month-old babies and one 4-year-old child) with a history of SBS in the first year of life presented with tractional retinal detachment due to severe preretinal fibrovascular proliferation. Peripheral retinal ischemia and vascular disorganization were noted during clinical examination. Although physiopathology of SBS remains disputed, ischemia has been accepted as the main feature of cerebral lesions. Ischemia could also be present at the retinal level as suggested by our patients' presentation. It could be induced by direct vitreous shearing of the capillary network or more probably by vascular leak due to brain edema and hypoxic damage of capillaries. Long-term ocular follow-up is necessary in SBS to treat these patients preventively.

8 May 2020 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SKSylvain El Khoury
Sylvain El Khoury
ACAna Clement
Ana Clement
ICIsmael Chehaibou
Ismael Chehaibou
YAYoussef Abdelmassih
Youssef Abdelmassih
CECatherine Edelson
Catherine Edelson
GCGeorge Caputo
George Caputo

11 February 2021 in Neonatology
Verified
Journal Article
Closed access
PDF file
TCThibaut Chapron
Thibaut Chapron
GCGeorges Caputo
Georges Caputo
VPVèronique Pierrat
Vèronique Pierrat
EKElsa Kermorvant
Elsa Kermorvant
ABAmandine Barjol
Amandine Barjol
HTHéloïse Torchin
Héloïse Torchin
Introduction: Retinopathy of prematurity (ROP) is a blinding disease that requires screening by retinal examination. Screening practices are rarely evaluated. We aimed to determine the prevalence of ROP screening in very preterm infants and individual- and center-related factors associated with ROP screening. Methods: Data were extracted from the EPIPAGE-2 cohort, a French prospective population-based study of premature births in 2011. Children born before 32 weeks’ gestation (WG) without severe malformation and alive at the recommended time for ROP screening were included. Outcome measures were achievement of ROP screening and compliance with recommended screening timeline. Individual- and center-related factors associated with both measures were studied using mixed models. Results: Among 3,077 eligible infants, 2,169 (70.5%) had a ROP screening, ranging from 96% at 24 WG to 50% at 31 WG. Large variability among units was observed. Individual characteristics associated with screening were low gestational age, low birth weight, severe bronchopulmonary dysplasia or neurological lesions, and transfer between neonatal units during the screening period. Odds of screening were higher in neonatal units using wide-angle imaging (odds ratio 2.65 [95% confidence interval 1.17–6.01]) but decreased in units without a local protocol for ROP screening (0.03 [0.01–0.09]). Among screened children, 1,641/2,169 (75.7%) were screened according to recommended timeline. Delayed screening was associated with low gestational age, severe bronchopulmonary dysplasia or necrotizing enterocolitis, and absence of local protocol for ROP screening. Discussion/Conclusions: In this large cohort study of infants born very preterm, almost one-third were not screened for ROP. Children most at risk for ROP were the best screened but often with delay. The higher compliance of neonatal units using wide-angle imaging systems supports its use.

30 May 2024 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
YAYoussef Abdelmassih
Youssef Abdelmassih
RLRégis Lecoge
Régis Lecoge
MHMehdi El Hassani
Mehdi El Hassani
PDPascal Dureau
Pascal Dureau
GCGeorges Caputo
Georges Caputo
TCThibaut Chapron
Thibaut Chapron

1 January 2021 in Ophthalmology
Verified
Journal Article
Closed access
GPGuillaume Poillon
Guillaume Poillon
AHAdrien Henry
Adrien Henry
OBOlivier Bergès
Olivier Bergès
FBFranck Bourdeaut
Franck Bourdeaut
KCKamal Chouklati
Kamal Chouklati
ASAnnick Sevely
Annick Sevely

6 June 2017
Verified
Book Chapter
Closed access
PDF file
GCGeorges Caputo
Georges Caputo
Pediatric vascular retinopathies involve children from their birth through their whole lifespan. They include acquired retinopathies like retinopathy of prematurity (ROP), congenital lesions like Coats disease, and genetic vasculopathies as in familial exudative vitreoretinopathy, incontinentia pigmenti, or Norrie's disease. The latter all share a common pathophysiological mechanism implicating the WNT signaling pathway. They are dominated by ROP and its devastating consequences if not properly addressed. Differential diagnosis can be challenging: medical history, family history are fundamental elements, and clinical characteristics need to be detailed with wide field angiography. The most effective treatment is laser ablative therapy of the ischemic retina or vascular anomalies in early stages of these diseases, vitrectomy surgery addressing the most severe ones with a poorer anatomical and functional prognosis. Anti-vascular endothelial growth factor is a helpful tool in these conditions, but should be used with caution in developing children.